Items where authors include "Girvan, S."

Article

Robinson, O.C., Boland, E.G., Day, F. et al. (14 more authors) (2025) Investigation of an integrated standardised pain assessment and management tool in addition to usual care versus usual care alone in oncology outpatient clinics for adults with pain: the CAPTURE cluster randomised pilot trial protocol. ISRCRN86926298. Pilot and Feasibility Studies, 11 (1). 127. ISSN 2055-5784

Robinson, O.C. orcid.org/0000-0002-3171-4407, Boland, E.G., Day, F. et al. (14 more authors) (2025) Investigation of an integrated standardised pain assessment and management tool in addition to usual care versus usual care alone in oncology outpatient clinics for adults with pain: the CAPTURE cluster randomised pilot trial protocol. ISRCRN86926298. Pilot and Feasibility Studies, 11 (1). 127. ISSN 2055-5784

Robinson, O.C. orcid.org/0000-0002-3171-4407, Day, F., Boland, E.G. et al. (14 more authors) (2025) Acceptability, fidelity and implementation of systematic integrated pain management in oncology outpatient services: a process evaluation protocol for a multicentre clustered randomised pilot trial. BMJ Open, 15 (6). ARTN e101935. ISSN 2044-6055

Munir, T., Girvan, S., Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (32 more authors) (2025) Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia. The New England Journal of Medicine. ISSN 0028-4793

Robinson, O.C., Day, F., Boland, E.G. et al. (14 more authors) (2025) Acceptability, fidelity and implementation of systematic integrated pain management in oncology outpatient services: a process evaluation protocol for a multicentre clustered randomised pilot trial. BMJ Open, 15 (6). e101935. ISSN 2044-6055

Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis or involved node treatment: eradicating recurrence in prostate cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14. e095560. ISSN 2044-6055

Slevin, F. orcid.org/0000-0002-7176-904X, Alexander, S., Brown, S.R. orcid.org/0000-0002-7975-7537 et al. (20 more authors) (2024) Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) – study protocol paper for a phase III multicentre, open-label randomised controlled trial. BMJ Open, 14 (12). e095560. ISSN 2044-6055

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Proceedings Paper

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.